Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol]: In Vitro StudiesBarbara Spagnolo, Girolamo Calò, Giacomo Carrà et al.|Journal of Pharmacology and Experimental Therapeutics|2007Cited by 97
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptorAnna Rizzi, Girolamo Calò, Barbara Spagnolo et al.|Peptides|2007Cited by 72
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5Valeria Camarda, Girolamo Calò, Carmela Fischetti et al.|Naunyn-Schmiedeberg s Archives of Pharmacology|2009Cited by 67
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acidsMarika Arduin, Severo Salvadori, Barbara Spagnolo et al.|Bioorganic & Medicinal Chemistry|2007Cited by 59
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24Carmela Fischetti, Girolamo Calò, Valeria Camarda et al.|European Journal of Pharmacology|2009Cited by 38